Clinical trials
Phase 3 Dyslipidemias trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 6 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 6 |
| Amgen | 2 |
| Amarin Pharma Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 10 |
| Diabetes Mellitus | 6 |
| Diabetes Mellitus, Type 2 | 6 |
| Glucose Metabolism Disorders | 6 |
| Hypercholesterolemia | 3 |
| Acute Coronary Syndrome | 1 |
| Angina Pectoris | 1 |
| Arterial Occlusive Diseases | 1 |
| Arteriosclerosis | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.